RE: Further questioning CD34+CD19+

From: Timothy Singleton, M.D. (tsingleton@smtpgw.beaumont.edu)
Date: Wed Feb 07 2001 - 18:00:27 EST


I heard of a case where the donor's marrow for a bone marrow transplant had a high
percentage of hematogones.  This was back when marrows were being used for transplants.
The recipient had rapid marrow engraphment in record time.

Tim Singleton, MD
William Beaumont Hospital
Royal Oak, MI

>>> "Donnenberg, Albert" <donnenbergad@MSX.UPMC.EDU> 02/06/01 08:06PM >>>
Liza-
CD34 cell dose is really a surrogate marker for engraftable stem cells,
better than nucleated cells or colony forming units, but a surrogate
nonetheless.  It is a safe bet that CD19+ CD34+ cells do nothing for
neutrophil or platelet engraftment.  The significance of cells expressing
other lineage markers is less clear.  It is thought that myeloid
lineage-committed CD34+ progenitor cells contribute to early engraftment.

Albert Donnenberg


-----Original Message-----
From: Liza McGuire [mailto:l_mcguire@hendrix.jci.tju.edu]
Sent: Friday, February 02, 2001 6:24 PM
To: cyto-inbox
Subject: Further questioning CD34+CD19+


Hi flowers,

Thanks so much for responding to my initial question on the id of CD34+CD19+
cells (by the way, my observation has been in BM and mobilized PBPCs). It
made me further question the significance of this presence. Say, a patient
was infused with stem cells that were primarily committed to B-cells (b-cell
precursors). Would it have any clinical significance on the engraftment
outcome?
What if these stem cells were primarily CD34+CD33+; Would the clinical
outcome of the patient be different from the patient who received primarily
CD34+CD19+ cells?
Or, what if there was an equal distribution of both, CD34+CD19+ and
CD34+CD33+?
Does the stimulation regimen (G-CSF) for mobilizing stem cells play a role
in the choice of the stem cell differentiation pathway? Yet again, I have
seen this in Bone Marrow where there has been no stimulation at all.
Any takers?
Thanks again for your time,
Liza



Liza McGuire
Bone Marrow Transplant Laboratory, Supervisor
Thomas Jefferson University Hospital
130 S 9th Street, Rm. 400 Edison
Philadelphia, PA 19107-5233
(215)955-9646



This archive was generated by hypermail 2b29 : Sun Jan 05 2003 - 19:01:05 EST